Biotechnology Ultrasector Profund Fund Fundamentals
| BIPIX Fund | USD 45.85 0.62 1.37% |
Biotechnology Ultrasector Profund fundamentals help investors to digest information that contributes to Biotechnology Ultrasector's financial success or failures. It also enables traders to predict the movement of Biotechnology Mutual Fund. The fundamental analysis module provides a way to measure Biotechnology Ultrasector's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biotechnology Ultrasector mutual fund.
Biotechnology |
Biotechnology Ultrasector Profund Mutual Fund Annual Yield Analysis
Biotechnology Ultrasector's Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.
Current Biotechnology Ultrasector Annual Yield | 0 % |
Most of Biotechnology Ultrasector's fundamental indicators, such as Annual Yield, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biotechnology Ultrasector Profund is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
| Competition |
In accordance with the recently published financial statements, Biotechnology Ultrasector Profund has an Annual Yield of 0.0017%. This is much higher than that of the ProFunds family and significantly higher than that of the Trading--Leveraged Equity category. The annual yield for all United States funds is 99.41% higher than that of the company.
Biotechnology Ultrasector Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Biotechnology Ultrasector's current stock value. Our valuation model uses many indicators to compare Biotechnology Ultrasector value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Biotechnology Ultrasector competition to find correlations between indicators driving Biotechnology Ultrasector's intrinsic value. More Info.Biotechnology Ultrasector Profund is fourth largest fund in price to earning among similar funds. It is the top fund in price to book among similar funds fabricating about 2.19 of Price To Book per Price To Earning. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Biotechnology Ultrasector's earnings, one of the primary drivers of an investment's value.Biotechnology Annual Yield Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biotechnology Ultrasector's direct or indirect competition against its Annual Yield to detect undervalued stocks with similar characteristics or determine the mutual funds which would be a good addition to a portfolio. Peer analysis of Biotechnology Ultrasector could also be used in its relative valuation, which is a method of valuing Biotechnology Ultrasector by comparing valuation metrics of similar companies.Biotechnology Ultrasector is currently under evaluation in annual yield among similar funds.
Fund Asset Allocation for Biotechnology Ultrasector
The fund consists of 75.46% investments in stocks, with the rest of investments allocated between different money market instruments.Asset allocation divides Biotechnology Ultrasector's investment portfolio among different asset categories to balance risk and reward by investing in a diversified mix of instruments that align with the investor's goals, risk tolerance, and time horizon. Mutual funds, which pool money from multiple investors to buy a diversified portfolio of securities, use asset allocation strategies to manage the risk and return of their portfolios.
Mutual funds allocate their assets by investing in a diversified portfolio of securities, such as stocks, bonds, cryptocurrencies and cash. The specific mix of these securities is determined by the fund's investment objective and strategy. For example, a stock mutual fund may invest primarily in equities, while a bond mutual fund may invest mainly in fixed-income securities. The fund's manager, responsible for making investment decisions, will buy and sell securities in the fund's portfolio as market conditions and the fund's objectives change.
Biotechnology Fundamentals
| Price To Earning | 2.37 X | ||||
| Price To Book | 5.19 X | ||||
| Price To Sales | 4.56 X | ||||
| Total Asset | 113.86 M | ||||
| Annual Yield | 0 % | ||||
| Year To Date Return | 1.42 % | ||||
| One Year Return | (6.12) % | ||||
| Three Year Return | 3.37 % | ||||
| Five Year Return | 5.86 % | ||||
| Ten Year Return | 24.20 % | ||||
| Net Asset | 116.96 M | ||||
| Minimum Initial Investment | 15 K | ||||
| Cash Position Weight | 24.54 % | ||||
| Equity Positions Weight | 75.46 % |
About Biotechnology Ultrasector Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biotechnology Ultrasector Profund's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biotechnology Ultrasector using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biotechnology Ultrasector Profund based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.The fund invests in financial instruments that the fund advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index represents the biotechnology segment of the SP Total Market Index, which comprises the following sub-industry biotechnology. The fund is non-diversified.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Biotechnology Mutual Fund
Biotechnology Ultrasector financial ratios help investors to determine whether Biotechnology Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biotechnology with respect to the benefits of owning Biotechnology Ultrasector security.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |